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Cardiac fibrosis contributes to both systolic and diastolic dysfunction in many cardiac pathophysiologic conditions. Antifibrotic therapies are likely to be a crucial strategy in curbing many fibrosis-related cardiac diseases. In our previous study, an ethyl acetate extract of a traditional Chinese medicine Aristolochia yunnanensis Franch. was found to have a therapeutic effect on myocardial fibrosis in vitro and in vivo. However, the exact chemicals and their mechanisms responsible for the activity of the crude extract have not been illustrated yet. In the current study, 10 sesquiterpenoids (1-10) were isolated from the active extract, and their antifibrotic effects were systematically evaluated in transforming growth factor β 1 (TGFβ1)-stimulated cardiac fibroblasts and NIH3T3 fibrosis models. (+)-Isobicyclogermacrenal (1) and spathulenol (2) were identified as the main active components, being more potent than the wellknown natural antifibrotic agent oxymatrine. Compounds 1 and 2 could inhibit the TGFβ1-induced cardiac fibroblasts proliferation and suppress the expression of the fibrosis biomarkers fibronectin and α-smooth muscle actin via down-regulation of their mRNA levels. The mechanism study revealed that 1 and 2 could inhibit the phosphorylation of TGFβ type I receptor, leading to the decrease of the phosphorylation levels of downstream Smad2/3, then consequently blocking the nuclear translocation of Smad2/3 in the TGFβ/Smad signaling pathway. These findings suggest that 1 and 2 may serve as promising natural leads for the development of anticardiac fibrosis drugs. is the main cause of hypertensive heart disease and myocardial infarction (Berk, Fujiwara, & Lehoux, 2007; Dobaczewski, GonzalezQuesada, & Frangogiannis, 2010) . Sustained ECM accumulation will lead to the myocardial stiffness and diastolic dysfunction of the heart and eventually lead to heart failure. Both experimental and clinical evidences suggest that cardiac fibrotic alterations may be reversible (Dewald et al., 2003; Lim et al., 2001) . Thus, the inhibition of cardiac fibrosis plays an important role in prevention and treatment of the cardiovascular diseases.
Cardiac fibroblasts, which account for 60-70% of the cells in the human heart, are key source of the components of ECM (Jugdutt, 2003) . In all conditions associated with cardiac fibrosis, the transdifferentiation of fibroblasts into secretory and contractile cells, termed myofibroblasts, is the key cellular event that drives the fibrotic response. Myofibroblasts could express contractile proteins and exhibit increased migratory, proliferative, and secretory properties.
The key hormones and cytokines involved in this transdifferentiation are Angiotensin II, endothelin-1, and transforming growth factor β 1 (TGFβ1; Chen et al., 2018) . Among them, TGFβ1 is a critical factor existing as a secreted latent form in the normal heart, and once activated could phosphorylate TGFβ type I and TGFβ type II receptors (TβRI and TβRII). The phosphorylated TβRI could further phosphorylate small mother against decapentaplegic 2/3 (Smad2/3) to produce phosphorylated Smad2/3. The phosphorylated Smad2/3 could bind to Smad4 and translocate into the nucleus, finally activating gene transcription of ECM Hu et al., 2018; . Therefore, the TGFβ/Smad signaling pathway plays a crucial role in cardiac fibrosis. In addition, extracellular signal-regulated kinase (ERK) was also found to be an important modulator in cardiac fibroblasts (Gao et al., 2009; Yang, Chung, Huang, & Lan, 2009 ). Activation of the ERK signaling pathway by various stimuli has been correlated to cell proliferation and remodeling of ECM (Yoon & Seger, 2006) . Therefore, suppression of the TGFβ/Smad or ERK signaling pathways has been considered as a promising therapeutic strategy for cardiac fibrosis.
However, owing to its biological complexity and its close relationship with diverse devastating pathological conditions, the discovery and development of novel antifibrotic therapeutics remains a crucial challenge. Although a number of widely prescribed cardiovascular drugs have shown pleiotropic effects on cardiac fibrosis and myocardial remolding, their unclear action mechanisms and side effects limited their clinical use. (Gourdie, Dimmeler, & Kohl, 2016) . Thus, the search for novel antifibrotic agents with precise mechanisms and less side effects is still compelling.
Aristolochia yunnanensis Franch. (Aristolochiaceae), endemic to
Yunnan Province of China, is known as "Nan Mu Xiang" in traditional Chinese medicine (TCM) for the treatment of gastrointestinal diseases, trichomoniasis, and rheumatic pain (Song, 1999) . Previous chemical investigation of this plant revealed that sesquiterpenoids were principal constituents, and some of them showed activity in anticancer research (Chen, Mayer, Zimmermann, & Rücker, 1989; Choi et al., 2012) . In our previous study on this plant, we found that an ethyl acetate fraction of its ethanolic extract had a therapeutic effect on myocardial fibrosis in vitro and in vivo, which exerted its effects via inhibiting TGFβ/Smad and MAPK/ERK signaling pathways (Shao et al., 2014) . In addition, the chemical investigation of this plant led to the isolation of a series of sesquiterpenoids, including some of new compounds (Cheng et al., 2013) . However, the chemicals responsible for the antifibrotic effects of the active crude extract and their relevant mechanisms have not been illustrated yet. In the present study, the antifibrotic effects of 10 sesquiterpenoids (1-10) from the active extract of A. yunnanensis were evaluated, and (+)-isobicyclogermacrenal (1) and spathulenol (2) were identified to be the main active components, being more potent than the well-known natural antifibrotic agent oxymatrine (OMT). The mechanism study revealed that (+)-isobicyclogermacrenal (1) and spathulenol (2) could inhibit the TGFβ/Smad signaling pathway via inhibition on the phosphorylation of TβRΙ. Figure S1 ) from the ethyl acetate extract of A. yunnanensis. The isolation and structure elucidation processes were described in our previous publication (Cheng et al., 2013 , also see Supporting Information). The purity of compounds was confirmed by nuclear magnetic resonance (NMR) and HPLC methods, which was greater than 95% ( Figures S2-S21 ).
| Rat cardiac fibroblasts isolation and culture
Animal handling and the experimental procedures were conforming to the Guidelines of Animal Experiments from Ethical Committee for Animal Research of Sun Yat-sen University (approval number: IACUC-DD-17-0710). Primary cultured adult rat cardiac fibroblasts were prepared as described in our previous study (Shao et al., 2014) . Briefly, male Sprague Dawley rats (180-220 g) were anesthetized by intraperitoneal injection of sodium pentobarbital (30 mg/kg). The hearts from rats were minced and digested in 0.1% collagenase II for three 30 min, 0.25% trypsin for three 5 min periods. Cells were collected and suspended in DMEM containing 10% FBS. After 1 hr incubation, the debris and nonadherent cells were removed, and the attached cells were cultured in a humidified atmosphere containing 5% CO 2 at 37°C. Cardiac fibroblasts were cultured for 3-4 days and passaged further. The second to fourth passages of the cardiac fibroblasts were used in the current study.
| NIH3T3 culture
NIH3T3 cell line was provided by Prof. Xian-Zhang Bu, School of Pharmaceutical Sciences, Sun Yat-sen University (Guangzhou, China).
NIH3T3 cells were cultured at 37°C in a humidified incubator with 5% CO 2 . The culture medium was DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin.
| Cytotoxicity assay
Cell viability was measured using the MTT assay. Briefly, cardiac fibroblasts (5,000 per well) were seeded into each well of a 96-well plate and treated with (+)-isobicyclogermacrenal (1) and spathulenol (2) at three different concentrations (30, 60, and 90 μM) for 48 hr.
After then, 20 μl MTT-phosphate buffer saline solution (5 mg/ml) was added to each well. The plate was incubated for another 4 hr at 37°C. The absorbance was measured at 570 nm with a multifunction microplate reader (Molecular Devices, Flex Station 3).
Cells were plated in triplicates, and experiments were repeated three times.
| Proliferation assay
Cell proliferation stimulated by TGFβ1 was measured using the CCK8 assay. Briefly, cardiac fibroblasts (5,000 per well) were seeded into each well of a 96-well plate. Cells were treated with (+)-isobicyclogermacrenal (1) and spathulenol (2) at three different concentrations (15, 30, and 60 μM) for 1 hr and then stimulated by TGFβ1 (10 ng/ml) for 48 hr. Cell proliferation was analyzed with CCK8 kit, according to the manufacturer's instruction. The absorbance was measured at 450 nm with a multifunction microplate reader (Molecular Devices, Flex Station 3). Cells were plated in triplicates, and experiments were repeated three times.
FIGURE 1
The structures of sesquiterpenoids 1-10 from the ethyl acetate extract of Aristolochia yunnanensis (a) and inhibitory effects on the cardiac fibrotic biomarker fibronectin (FN) in cardiac fibroblasts stimulated by transforming growth factor β 1 (TGFβ1; b-c). Cardiac fibroblasts were pretreated with 50 μM each of 1-10 for 1 hr and then stimulated with 10 ng/ml TGFβ1 for another 12 hr. Proteins from total lysates were subjected to sodium dodecylsulfate polyacrylamide gel electrophoresis, followed by western blot with indicated antibodies. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. The blots were then quantified by densitometry (n = 3, *** P < 0.001 vs. vehicle treatment; # P < 0.05 and ### P < 0.001 vs. TGFβ1 only, analysis of variance) binding sites on the membranes were blocked by 5% nonfat milk for 2 hr at room temperature, followed by incubated with the primary antibodies at 1:1,000 dilution overnight at 4°C and then incubated with specific secondary antibodies at 1:5,000 dilution for 1 hr at room temperature. The bands were detected by LAS4000 imager (GE, USA).
| Immunofluorescence assay
Cardiac fibroblasts were cultured on confocal dishes, pretreated with (+)-isobicyclogermacrenal (1) (30 μM), spathulenol (2) (30 μM), or SB431542 (10 μM) for 1 hr, and then exposed to TGFβ1 (10 ng/ml) or activin A (50 ng/ml) for an additional 30 min or 1 hr. The cells were successively washed (three times with phosphate buffer saline), fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.1% Triton X-100 for 30 min at room temperature, blocked for 30 min with normal goat serum, and then followed by incubation with Smad2 or Smad3 (1:800 dilution) overnight at 4°C. After a wash step, cells were incubated with Alexa 555-labeled anti-rabbit IgG (red) (1:1,000 dilution) for 1 hr at room temperature, and the nucleus was stained by 4′,6-diamidino-2-phenylindole for another 10 min in the dark at room temperature. The images were acquired using a Zeiss LSM710 confocal microscope (Zeiss, Oberkochen, Germany).
| Quantitative real-time reverse transcription-polymerase chain reaction
Cardiac fibroblasts (3 × 10 5 per well) were seeded into a six-well plate.
The cells were pretreated with indicated concentrations of (+)-isobicyclogermacrenal (1) and spathulenol (2) for 1 hr and then stimu- Quantification of transcript levels of FN, α-SMA, and collagen Ι and ΙΙΙ gene were conducted according to the 2 −ΔΔCt method. The expression data of these proteins were denoted as means ± standard deviation.
The PCR primers used in this study were shown in Table S1 .
| Statistical analysis
All statistical analyses were performed using GraphPad Prism version 5.0 software (GraphPad Software San Diego; CA, USA). Independent experiments involved triplicate analyses for each sample conditions.
The data were presented as means ± standard deviation. Differences were considered to be statistically significant when P values were less than 0.05. 
| Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on TGFβ1-induced cardiac fibroblasts proliferation and the cytotoxicity
Excessive proliferation of cardiac fibroblasts is one of major processes in cardiac fibrosis. As shown in Figure S22a , the TGFβ1-induced proliferation of cardiac fibroblasts was significantly inhibited by the treatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) at the concentrations of 60 and 30 μM. To exclude the antiproliferation effect was caused by the cytotoxicity, the cell viability of cardiac fibroblasts were tested by the treatments of these compounds at different concentrations. As shown in Figure S22b , (+)-isobicyclogermacrenal (1) and spathulenol (2) had no obvious inhibition on the viability of cardiac fibroblasts at the concentration of 60 μM. So the concentrations of tested compounds in the following experiments were set below 60 μM.
3.3 | Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on the cardiac fibrotic biomarkers FN and α-SMA α-SMA is a crucial biomarker for cardiac fibroblasts differentiation into myofibroblasts. The inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on TGFβ1-induced FN and α-SMA production were further tested in cardiac fibroblasts and NIH3T3 cells. OMT, a well-known natural antifibrotic agent (Chen et al., 2008; Wu, Zeng, Jiang, Qin, & Xu, 2008) , and SB431542, an inhibitor of TGFβ1 signaling pathway (Davies et al., 2016; Koh et al., 2015) , were used as the positive controls. As shown in Figure 2a ,b, the treatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) at 30 μM effectively down-regulated the levels of FN and α-SMA in both cell lines. These inhibitory effects on FN were stronger than the treatment of 2 mM FIGURE 2 Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on the cardiac fibrotic biomarkers fibronectin (FN) and α-smooth muscle actin (α-SMA) in transforming growth factor β 1 (TGFβ1)-stimulated cardiac fibroblasts or NIH3T3. (a-b) The protein levels of FN and α-SMA in cardiac fibroblasts or NIH3T3 with treatments of (+)-isobicyclogermacrenal (1), spathulenol (2), oxymatrine (OMT), and SB431542 at indicated concentrations. (c-d) The protein levels of FN and α-SMA in cardiac fibroblasts with treatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) at different dose. The cells were stimulated with 10 ng/ml TGFβ1 for another 12 hr. The protein levels of FN and α-SMA were determined by western blot with indicated antibodies. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. The blots were then quantified by densitometry (n = 3, * P < 0.05 and *** P < 0.001 vs. vehicle treatment; # P < 0.05, OMT and comparable with the treatment of 10 μM SB431542, whereas these effects on α-SMA were weaker than the treatment of SB431542. The treatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) at different dose (3, 10, and 30 μM) were also investigated in cardiac fibroblasts (Figure 2c,d ), which showed a good dosedependent manner on FN and α-SMA inhibition. All these results suggested that (+)-isobicyclogermacrenal (1) and spathulenol (2) were potential antifibrotic agents, being more potent than OMT.
3.4 | Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on the mRNA levels of FN, α-SMA, and collagen Ι and ΙΙΙ In order to verify whether the compounds regulate the target proteins at the transcriptional level, the inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on the mRNA levels of FN, α-SMA, and collagen I and III were investigated in cardiac fibroblasts. As shown in Figure 3 , when cardiac fibroblasts were stimulated by 10 ng/ml TGFβ1, the mRNA levels of FN, α-SMA, and collagen Ι and ΙΙΙ were elevated. The treatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) could effectively down-regulate the corresponding mRNA levels in a dose-dependent manner. This indicated that the compounds suppressed the expression of the fibrosis biomarkers via down-regulation of their mRNA levels.
| Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on the phosphorylation of TβRI
TGFβ signaling is transduced by the receptors TβRI and TβRII to initiate the signaling events in cardiac fibrosis. To explore the antifibrotic mechanism of (+)-isobicyclogermacrenal (1) and spathulenol (2) in TGFβ signaling pathway, the phosphorylation levels of TβRI and TβRII were studied. As shown in Figure 4a ,b, the phosphorylation levels of TβRI and TβRII were increased by the stimulation of 10 ng/ml TGFβ1 for 30 min, whereas the protein levels of TβRI and TβRII were not changed. The treatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) at 30 μM significantly decreased the phosphorylated TβRI while had no effect on phosphorylated TβRII and the proteins levels of TβRI and TβRII. These results indicated that (+)-isobicyclogermacrenal (1) and spathulenol (2) could inhibit TGFβ signaling via the regulation of phosphorylated TβRI.
3.6 | Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on the phosphorylation of Smad3 and Smad2
In fibroblasts, Smad3 and Smad2 are two important intracellular mediators in the downstream of TGFβ signaling, which could be phosphorylated by the actived TβRI (Derynck & Zhang, 2003) . Thus, the inhibition on the phosphorylation of TβRI is supposed to decrease the phosphorylation of Smad3 and Smad2. To verify this, the phosphorylation of Smad3 and Smad2 was studied. As shown in Figure 4 c,d, the phosphorylated levels of Smad3 and Smad2 were significantly elevated in cardiac fibroblasts stimulated by 10 ng/ml TGFβ1 for 30 min, whereas the treatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) effectively inhibited the phosphorylation of Smad3 (Figure 4c ,e) and Smad2 (Figure 4d,f) , respectively, in a dosedependent manner. During this process, the total levels of Smad3 and Smad2 were not changed, indicating that regulation occurred after the normal expression of Smad2 and Smad3 proteins.
FIGURE 3 Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on the mRNA levels of fibronectin (FN), α-smooth muscle actin (α-SMA), and collagen Ι and ΙΙΙ in transforming growth factor β 1 (TGFβ1)-stimulated cardiac fibroblasts. Cardiac fibroblasts were pretreated with the indicated concentrations of (+)-isobicyclogermacrenal (1) and spathulenol (2) for 1 hr and then stimulated with 10 ng/ml TGFβ1 for another 12 hr. The mRNA levels of FN, α-SMA, and collagen Ι and ΙΙΙ from cardiac fibroblasts were detected by quantitative real-time reverse transcriptionpolymerase chain reaction (qRT-PCR). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control (n = 3, *** P < 0.001 vs. vehicle treatment; # P < 0.05, ## P < 0.01, and ### P < 0.001 vs. TGFβ1 only, analysis of variance)
3.7 | Inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on nuclear translocation of Smad3 or Smad2
The intensity, whereas pretreatments of (+)-isobicyclogermacrenal (1) and spathulenol (2) (30 μM for 1 hr) reversed the distribution of Smad3 and Smad2 in nucleus, respectively. These results indicated that the nuclear translocation of Smad3 and Smad2 was blocked by (+)-isobicyclogermacrenal (1) and spathulenol (2), respectively. As activin A is a crucial member in TGFβ superfamily, which could also modulate the nuclear translocation of Smad2/3 in cardiac fibrosis by activation of the activin type II and I receptors (Hedger & de Kretser, 2013) , the inhibitory effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on activin A-induced Smad2/3 nuclear translocation were also investigated. The results ( Figure S23) showed that (+)-isobicyclogermacrenal (1) and spathulenol (2) had no inhibitory effect 3.8 | Effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) on ERK signaling pathway As ERK signaling pathway also plays an important role in cardiac fibrosis, and our previous study suggested that the active fraction could also target this signaling pathway, the effects of (+)-isobicyclogermacrenal (1) and spathulenol (2) onTGFβ1-induced phosphorylation of ERK1/2 were examined. However, the results showed that (+)-isobicyclogermacrenal (1) and spathulenol (2) had no inhibitory effect on the phosphorylated ERK1/2 at the concentration of 30 μM ( Figure S24 ), indicating (+)-isobicyclogermacrenal (1) and spathulenol (2) had no effect on ERK signaling pathway. TCM has proved to be a rich source of antifibrotic agents. Compounds isolated from TCM, such as tanshinone IIA (Huang, Zhu, Zheng, Zou, & Zhou, 2018) , ginsenoside-Rg1, curcumin (Zhang et al., 2013) , astragaloside IV (Li et al., 2013) , quercetin (Lu et al., 2015) , 3-[(Z)-Pentadec-8-enyl] catechol (Ai et al., 2015) , baicalin , and dioscin (Li, Zhu, Wang, Yuan, & Zhu, 2017) , were widely reported to alleviate the organ fibrosis via comprehensive mechanism. Thus, the search for novel antifibrotic agents from natural resource is a shortcut in antifibrosis drug development.
In the current study, the antifibrotic effects of 10 sesquiterpenoids from a TCM A. yunnanensis were investigated for the first time. Among them, (+)-isobicyclogermacrenal (1) and spathulenol (2) 
